2021

Link

Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy for a Cancer Diagnosis., Amy E McGhee-Jez, Inna Chervoneva, Misung Yi, Amisha Ahuja, Ritu Nahar, Samik Shah, Rebecca Loh, Sarah Houtmann, Rashesh Shah, Charles J Yeo, Harish Lavu, Steven J Cohen, Dina Halegoua-DeMarzio, and Atrayee Basu Mallick (Article)

Link

Multidisciplinary consensus recommendations for the management of non-spine bone metastases: Results of a modified Delphi process in a community-academic partnership., Alyson McIntosh MD and Ranju Gupta (Article)

Link

Impact of Cannabis Use on Least Pain Scores Among African American and White Patients with Cancer Pain: A Moderation Analysis., Salimah H Meghani, Ryan Quinn, Rebecca Ashare, Kristin Levoy, Brooke Worster, Mary Naylor, Jesse Chittams, and Martin Cheatle (Article)

Link

Metabolic Pathways and Targets in Chondrosarcoma., Ida Micaily, Megan Roche, Mohammad Y Ibrahim, Ubaldo Martinez-Outschoorn, and Atrayee Basu Mallick (Article)

Link

Single cell biomass tracking allows identification and isolation of rare targeted therapy-resistant DLBCL cells within a mixed population., Graeme F Murray, Daniel Guest, Andrey Mikheykin, Amir Toor MD, and Jason Reed (Article)

Link

Engaging Patients with Late-Stage Non-Small Cell Lung Cancer in Shared Decision Making about Treatment., Ronald E Myers, Shailesh M Advani, Pamela Myers, Preethi Selvan, Gregory Garber, Brooke Worster, Neal Flomenberg, Andrew Chapman, and Ralph Zinner (Article)

Link

Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study), Michael A. Postow, Debra A. Goldman, Alexander N. Shoushtari, Allison Betof Warner, Margaret K. Callahan, Parisa Momtaz, James W. Smithy, Ellesa Naito, Marina K. Cugliari, Vladislav Raber, Omar Eton, Suresh G. Nair MD, Katherine S. Panageas, Jedd D. Wolchok, and Paul B. Chapman (Article)

Link

Acute Infusion-Related Reactions: How to Recognize and Intervene When These Reactions Occur in Practice, Maura Price RN, BSN, OCN (Article)

Link

Wnt signaling establishes the microtubule polarity in neurons through regulation of Kinesin-13., Dharmendra Puri, Keerthana Ponniah, Kasturi Biswas, Atrayee Basu, Swagata Dey, Erik A Lundquist, and Anindya Ghosh-Roy (Article)

Link

Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation., Rima M Saliba, Lauren Veltri, Gabriela Rondon, Julianne Chen, Gheath Al-Atrash, Amin Alousi, Charles Martinez, LaJerald Augustine, Chitra M Hosing, Betul Oran, Katayoun Rezvani, Elisabeth J Shpall, Partow Kebriaei, Issa F Khouri, Uday Popat, Richard E Champlin, and Stefan O Ciurea (Article)

Link

Racial Disparities in Rates of Surgery for Esophageal Cancer: a Study from the National Cancer Database., Samantha L Savitch, Tyler R Grenda, Walter Scott, Scott W Cowan, James Posey, Edith P Mitchell, Steven J Cohen, Charles J Yeo, and Nathaniel R Evans (Article)

PDF

A Retrospective Review of LVHN Compliance With Diagnostic Workup For Pancreatic Cancer Per NCCN Guidelines, Caitlin Scialla; Dennis Sopka MD; Savitri Skandan MD; and Melissa Kratz RN, MSN, AOCN (Poster)

Link

Subgroup analyses of patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC) treated with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line (1L) therapy:Two-year clinical update., Usman Shah MD (Article)

Link

The Effects of Physical Activity on Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors: A Scoping Review., Amy L Shaver, Swapnil Sharma, Nikita Nikita, Daniel S Lefler, Atrayee Basu-Mallick, Jennifer M Johnson, Meghan Butryn, and Grace Lu-Yao (Article)

Link

Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas., Alexander N Shoushtari, Walid K Chatila, Arshi Arora, Francisco Sanchez-Vega, Havish S Kantheti, Jorge A Rojas Zamalloa, Penina Krieger, Margaret K Callahan, Allison Betof Warner, Michael A Postow, Parisa Momtaz, Suresh G. Nair MD, Charlotte E Ariyan, Christopher A Barker, Mary Susan Brady, Daniel G Coit, Neal Rosen, Paul B Chapman, Klaus J Busam, David B Solit, Katherine S Panageas, Jedd D Wolchok, and Nikolaus Schultz (Article)

Link

Evaluation of thrombophilia testing in the inpatient setting: A single institution retrospective review, Chun Siu, Zachary Wolfe, Martin DelaTorre, Erafat Rehim, Robert V. Decker MD, Kathryn Zaffiri MPH, and Bradley Lash (Article)

Link

Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study., Vivek Subbiah, Mimi I Hu, Lori J Wirth, Martin Schuler, Aaron S Mansfield, Giuseppe Curigliano, Marcia S Brose, Viola W Zhu, Sophie Leboulleux, Daniel W Bowles, Christina S Baik, Douglas Adkins, Bhumsuk Keam, Ignacio Matos, Elena Garralda, Justin F Gainor, Gilberto Lopes, Chia-Chi Lin, Yann Godbert, Debashis Sarker, Stephen G Miller, Corinne Clifford, Hui Zhang, Christopher D Turner, and Matthew H Taylor (Article)

Link

Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas., Jakub Svoboda, Steven M Bair, Daniel J Landsburg, Sunita Dwivedy Nasta, Sarah J Nagle, Stefan K Barta, Nadia Khan, Joanne Filicko-O'Hara, Sameh Gaballa, Lauren Strelec, Elise Chong, Sheryl Mitnick, Terease S Waite, Cara King, Hatcher Ballard, Matthew Youngman, James Gerson, John P Plastaras, Amit Maity, Agata M Bogusz, Stacy S Hung, Hisae Nakamura, Reza Nejati, Christian Steidl, Megan Lim, Marco Ruella, and Stephen J Schuster (Article)

Link

Cardiac risk factors and events in patients with prostate cancer commencing androgen deprivation therapy: Analysis from a tertiary care center in the Middle East., Talar Telvizian MD (Article)

Link

Gastroparesis and Gastrointestinal Dysmotility following COVID-19 Infection, Talar Telvizian MD (Article)

Link

Knowledge, beliefs, and practices related to cancer screening and prevention in Lebanon: community and social media users' perspectives., Talar Telvizian MD, Yasmina Al Ghadban, Jude Alawa, Deborah Mukherji, Nathalie K Zgheib, Bisher Sawaf, Rihab Nasr, and Marco Bardus (Article)

PDF

Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis., Paaladinesh Thavendiranathan, Lili Zhang, Amna Zafar, Zsofia D Drobni, Syed S Mahmood, Marcella Cabral, Magid Awadalla, Anju Nohria, Daniel A Zlotoff, Franck Thuny, Lucie M Heinzerling, Ana Barac, Ryan J Sullivan, Carol L Chen, Dipti Gupta, Michael C Kirchberger, Sarah E Hartmann, Jonathan W Weinsaft, Hannah K Gilman, Muhammad A. Rizvi MD, Bojan Kovacina, Caroline Michel, Gagan Sahni, Ana González-Mansilla, Antonio Calles, Francisco Fernández-Avilés, Michael Mahmoudi, Kerry L Reynolds, Sarju Ganatra, Juan José Gavira, Nahikari Salterain González, Manuel García de Yébenes Castro, Raymond Y Kwong, Michael Jerosch-Herold, Otavio R Coelho-Filho, Jonathan Afilalo, Eduardo Zataraín-Nicolás, A John Baksi, Bernd J Wintersperger, Oscar Calvillo-Arguelles, Stephane Ederhy, Eric H Yang, Alexander R Lyon, Michael G Fradley, and Tomas G Neilan (Article)

Link

Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples, Scott A. Tomlins, Daniel H. Hovelson, Jennifer M. Suga, Daniel M. Anderson, Han A. Koh, Elizabeth C. Dees, Brendan McNulty, Mark E. Burkard, Michael Guarino, Jamil Khatri, Malek M. Safa, Marc R. Matrana, Eddy S. Yang, Alex R. Menter, Benjamin M. Parsons, Jennifer N. Slim, Michael A. Thompson, Leon Hwang, William J. Edenfield, and Suresh G. Nair MD (Article)

Link

522 - Hematopoietic Cell Transplant Donor Selection in a Patient with an RTEL1 Mutation and Myelodysplastic Syndrome, Amir Toor MD (Article)

Link

61 - Interaction Analysis of Donor Inhibitory KIR Content Following HLA Matched Unrelated Donor HCT for AML, Amir Toor MD (Article)

Link

Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?, Antonino C Tralongo, Roberto S Fratamico MD, Chiara Russo, Andrea Sbrana, Andrea Antonuzzo, and Marco Danova (Article)

Link

Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience., Alessandra Vecchié, Georgia Thomas, Edoardo Bressi, Aldo Bonaventura, Justin M Canada, David Chuquin, Dinesh Kadariya, Usman Piracha, Delia Endicott, Roshanak Markley, Amir Toor MD, Michael Hess, and Antonio Abbate (Article)

Link

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART), Michael J. Wagner, Megan Othus, Sandip P. Patel, Chris Ryan, Ashish Sangal, Benjamin Powers, G Thomas Budd, Adrienne I. Victor, Chung-Tsen Hsueh, Rashmi Chugh, Suresh G. Nair MD, Kirsten M. Leu, Mark Agulnik, Elad Sharon, Edward Mayerson, Melissa Plets, Charles Blanke, Howard Streicher, Young Kwang Chae, and Razelle Kurzrock (Article)

Link

Whom should we treat with novel agents? Specific indications for specific and challenging populations., Lindsay Wilde and Margaret Kasner (Article)

Link

First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer., Arthur Winer, Crystal S Denlinger, Namrata Vijayvergia, Steven J Cohen, Igor Astaturov, Efrat Dotan, Jean-Nicolas Gallant, Edward W Wang, Miriam Kunkel, Bora Lim, Harold A Harvey, Jeffrey Sivik, Kenneth Korzekwa, Karen Ruth, Kevin White, Harry S Cooper, Eric A Ross, Lanlan Zhou, and Wafik S El-Deiry (Article)

Link

Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer., Lori J Wirth, Marcia S Brose, Eric J Sherman, Lisa Licitra, Martin Schlumberger, Steven I Sherman, Keith C Bible, Bruce Robinson, Patrice Rodien, Yann Godbert, Christelle De La Fouchardiere, Kate Newbold, Christopher Nutting, Soamnauth Misir, Ran Xie, Ana Almonte, Weifei Ye, and Maria E Cabanillas (Article)

Link

Piloting the REDUCE score to decrease acute care utilization, B Worster (Article)

Link

Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆., Karen Yee, Cristina Papayannidis, Norbert Vey, Michael J Dickinson, Kevin R Kelly, Sarit Assouline, Margaret Kasner, Karen Seiter, Mark W Drummond, Sung-Soo Yoon, Je-Hwan Lee, Steven Blotner, Lori Jukofsky, William E Pierceall, Jianguo Zhi, Silke Simon, Brian Higgins, Gwen Nichols, Annabelle Monnet, Susanne Muehlbauer, Marion Ott, Lin-Chi Chen, and Giovanni Martinelli (Article)

Link

Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]), Harry H. Yoon, Fang-Shu Ou, Gamini S. Soori, Qian Shi, Dennis A. Wigle, Robert P. Sticca, Robert Clell Miller, James L. Leenstra, Patrick J. Peller, Brenda Ginos, Erica Heying, Tsung-Teh Wu, Timothy F. Drevyanko, Stephen Ko, Bassam Ibrahim Mattar, Daniel A. Nikcevich, Robert J. Behrens, Maged Khalil MD, George P. Kim, and Steven R. Alberts (Article)

Link

TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumors., Ju-Yoon Yoon, Wei Jiang, Christopher R Orr, Chase Rushton, Stacey Gargano, Sharon J Song, Mitul Modi, Bryan Hozack, John Abraham, Atrayee Basu Mallick, John S J Brooks, Jason N Rosenbaum, and Paul J Zhang (Article)

Link

Dynamical Systems Modeling of Early-Term Immune Reconstitution with Different Anti-Thymocyte Globulin (ATG) Administration Schedules in Allogeneic Stem Cell Transplantation, Viktoriya Zelikson, Gary Simmons, Natasha Raman, Elizabeth Krieger, Anatevka Rebiero, Kelly Hawks, May Aziz, Catherine Roberts, Jason Reed, Ronald Gress, and Amir Toor MD (Article)

Link

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis., Daniel A Zlotoff, Malek Z O Hassan, Amna Zafar, Raza M Alvi, Magid Awadalla, Syed S Mahmood, Lili Zhang, Carol L Chen, Stephane Ederhy, Ana Barac, Dahlia Banerji, Maeve Jones-O'Connor, Sean P Murphy, Merna Armanious, Brian J Forrestal, Michael C Kirchberger, Otavio R Coelho-Filho, Muhammad A. Rizvi MD, Gagan Sahni, Anant Mandawat, Carlo G Tocchetti, Sarah Hartmann, Hannah K Gilman, Eduardo Zatarain-Nicolás, Michael Mahmoudi, Dipti Gupta, Ryan Sullivan, Sarju Ganatra, Eric H Yang, Lucie M Heinzerling, Franck Thuny, Leyre Zubiri, Kerry L Reynolds, Justine V Cohen, Alexander R Lyon, John Groarke, Paaladinesh Thavendiranathan, Anju Nohria, Michael G Fradley, and Tomas G Neilan (Article)

2020

Link

Research Capacity and Training Needs for Cancer in Conflict-Affected MENA Countries., Zahi Abdul-Sater, Elsa Kobeissi, Marilyne Menassa, Talar Telvizian MD, and Deborah Mukherji (Article)

PDF

Rare Presentation of a Rare Disease: Signet-Ring Cell Gastric Adenocarcinoma in Rothmund-Thomson Syndrome., Zeeshan Ali MD, Pritika S Manaktala, Saro Sarkisian MD, and Muhammad A. Rizvi MD (Article)

PDF

Thrombotic Thrombocytopenic Purpura Induced by Immune Checkpoint Inhibitiors: A Case Report and Review of the Literature., Zeeshan Ali MD, Muhammad Usman Zafar, Zachary Wolfe, Faisal Akbar, and Bradley Lash (Article)

Link

Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis., Kamil M Amer, Murty Munn, Dominick Congiusta, John A Abraham, and Atrayee Basu Mallick (Article)

Link

Pylorus Preserving Pancreaticoduodenectomy After Prior Esophagogastrectomy., Rachel Appelbaum MD, Daniel Kuehler MD, and Jeffrey Brodsky MD (Article)

PDF

Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis., Magid Awadalla, Syed S Mahmood, John D Groarke, Malek Z O Hassan, Anju Nohria, Adam Rokicki, Sean P Murphy, Nathaniel D Mercaldo, Lili Zhang, Daniel A Zlotoff, Kerry L Reynolds, Raza M Alvi, Dahlia Banerji, Shiying Liu, Lucie M Heinzerling, Maeve Jones-O'Connor, Rula B Bakar, Justine V Cohen, Michael C Kirchberger, Ryan J Sullivan, Dipti Gupta, Connor P Mulligan, Sachin P Shah, Sarju Ganatra, Muhammad A. Rizvi MD, Gagan Sahni, Carlo G Tocchetti, Donald P Lawrence, Michael Mahmoudi, Richard B Devereux, Brian J Forrestal, Anant Mandawat, Alexander R Lyon, Carol L Chen, Ana Barac, Judy Hung, Paaladinesh Thavendiranathan, Michael H Picard, Franck Thuny, Stephane Ederhy, Michael G Fradley, and Tomas G Neilan (Article)

Link

Identification Of Strn-Ntrk2 Rearrangement In A High Grade Sarcoma, With Good Clinical Response To Firstline Larotrectinib Therapy, A Basu Mallick (Article)

Link

Impact of Smoking and TP53 Mutations in Acute Myeloid Leukemia and Myelodysplastic Syndromes, Xia Bi MD, MS (Article)

Link

Acute Liver Failure From Exertional Heatstroke Can Result in Excellent Long-Term Survival With Liver Transplantation., Xia Bi MD, MS; Adam Deising; and Catherine Frenette (Article)

Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations., Priscilla K. Brastianos, Erin Twohy, Elizabeth Robins Gerstner, Timothy J. Kaufmann, A John Iafrate, Suriya A. Jeyapalan, David Eric Piccioni, Andrew B. Lassman, Camilo E. Fadul, David Schiff, Jennie Webster Taylor, Sajeel A. Chowdhary, Thomas J. Kaley, Tara Morrison MD, Priya Kumthekar, Susan Geyer, Daniel P. Cahill, Sandro Santagata, Frederick G. Barker, and Evanthia Galanis (Presentation)

Link

Activity and safety of larotrectinib in adult patients with TRK fusion cancer: An expanded data set, M Brose (Article)

Link

Lenvatinib (LEN) plus pembrolizumab (PEMBRO) for early-line treatment of advanced/recurrent endometrial cancer (EC)., M Brose (Article)

Link

Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer., M Brose (Article)

Link

A multicenter, randomized, double-blind, phase II study of lenvatinib (LEN) in patients (pts) with radioiodine-refractory differentiated thyroid cancer (RR-DTC) to evaluate the safety and efficacy of a daily oral starting dose of 18 mg vs 24 mg, M S. Brose (Article)

Link

Final analysis of RIFTOS MKI, a global, non-interventional study assessing the use of multikinase inhibitors (MKIs) for the treatment of patients with asymptomatic radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC), M S. Brose (Article)

Link

Larotrectinib treatment of advanced TRK fusion thyroid cancer, M S. Brose (Article)

Link

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: Final analysis of a multicentre, open-label, single-arm, phase 2 trial, M S. Brose (Article)

Link

ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancer, M S. Brose (Article)

Link

Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC), M S. Brose (Article)

Link

Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC), M S. Brose (Article)

Link

Selpercatinib in patients with treatment (Tx)-naïve RET-mutant medullary thyroid cancer (MTC), M S. Brose (Article)

Link

Identification of Expression Profiles Defining Distinct Prognostic Subsets of Radioactive-Iodine Refractory Differentiated Thyroid Cancer from the DECISION Trial., Jaume Capdevila, Ignacio Matos, Francesco M Mancuso, Carmela Iglesias, Paolo Nuciforo, Carles Zafon, Hector G Palmer, Zighereda Ogbah, Laura Muiños, Jorge Hernando, Guillermo Villacampa, Carol E Peña, Josep Tabernero, Marcia S Brose, Martin Schlumberger, and Ana Vivancos (Article)

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors., Young Kwang Chae, Megan Othus, Sandip P Patel, Mark Zalupski, Anup Kasi, Maged Khalil MD, Aparna Kalyan, Blase Polite, Sarah Fenton, Sewan Gurung, Christine McLeod, Francis J Giles, Helen X Chen, Elad Sharon, Edward Mayerson, Melissa Plets, Christopher W Ryan, Charles D Blanke, and Razelle Kurzrock (Presentation)

PDF

Pembrolizumab: An Immunotherapeutic Agent Causing Endocrinopathies., Abdul Chaudry, Misbat Chaudry MD, and Jonaid Aslam MD (Article)

Link

A phase II study investigating cabozantinib in patients with refractory metastatic colorectal cancer (AGICC 17CRC01), S J. Cohen and A Basu Mallick (Article)

Link

Oral Anticoagulants for Venous Thromboembolism (VTE) in Pancreatic Cancer: Friend or Foe, Steven J. Cohen (Article)

Link

A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer., S Lindsey Davis, Dana B Cardin, Safi Shahda, Heinz-Josef Lenz, Efrat Dotan, Bert H O'Neil, Ann M Kapoun, Robert J Stagg, Jordan Berlin, Wells A Messersmith, and Steven J Cohen (Article)

Link

1155TiP Pan-tumour study CheckMate 8TT for long-term follow-up of cancer survivors who have participated in trials investigating nivolumab, C Denlinger, G Lu, Suresh G. Nair MD, E Kalinka, F Hosein, J Li, and N Khushalani (Article)

Link

Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer., Efrat Dotan, Dana B Cardin, Heinz-Josef Lenz, Wells Messersmith, Bert O'Neil, Steven J Cohen, Crystal S Denlinger, Safi Shahda, Igor Astsaturov, Ann M Kapoun, Rainer K Brachmann, Shailaja Uttamsingh, Robert J Stagg, and Colin Weekes (Article)

Link

Impaired CD4+ T-Cell Recovery after Autologous Stem Cell Transplantation in Patients with Myeloma and Lymphoma in the Modern Era, Joanne Filicko-O'Hara (Article)

Link

Inpatient Versus Outpatient Hypomethylating Agent Induction for AML As a Predictor for Survival, Joanne Filicko-O'Hara (Article)

PDF

A Retrospective Review of Outcomes Associated With Treatment Modalities Utilized In The Management of Diffuse Large B Cell Non-Hodgkin's Lymphoma, Benjamin Fry; Donna Colabroy RN, MSN, OCN, CCM; Melissa Kratz RN, MSN, AOCN; Dennis Sopka MD; and Savitri Skandan MD (Poster)

Link

The Impact of Low Hemoglobin Levels on Cognitive Brain Functions., Boula S Gattas, Crystal N Ibetoh, Eugeniu Stratulat, Fan Liu, George Y Wuni, Ronak Bahuva, Muhammad A Shafiq, and Domonick K Gordon (Article)

Link

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma (MCL): Outcomes with Haploidentical Donors at the Sidney Kimmel Cancer Center (SKCC), Usama Gergis MD, MBA (Article)

Link

Seven Years of Haplo-Cord Transplantation: Immune Reconstitution and Outcomes Using Anti-Thymocyte Globulin, Usama Gergis MD, MBA (Article)

Link

The Impact of Education on LN Harvesting for Gastric and Esophageal Cancer Specimens., Alanna Gretschel, Kelly Carman, Caroline Medin, James Dove, Kyo Chu, and Jacqueline Oxenberg DO (Article)

Pertuzumab plus trastuzumab (P+T) in patients (Pts) with colorectal cancer (CRC) with ERBB2 amplification or overexpression: Results from the TAPUR Study, Ranju Gupta MD, Elizabeth Garret-Mayer, Susan Halabi, Pam K. Mangat, Stacy D. D'Andre, Eyal Meiri, Sagun Shrestha, Sasha L. Warren, Shamika Ranasinghe, and Richard L. Schilsky (Presentation)

Link

Pelvic examination: an iatrogenic cause of microscopic hematuria in women?, Rima Hajjar, Talar Telvizian MD, Fady Constantinos, Omar Baba, and Tony Bazi (Article)

Link

Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer., Glenn J Hanna, Jeffrey P Guenette, Nicole G Chau, Cyrus M Sayehli, Christian Wilhelm, Robert Metcalf, Deborah J Wong, Marcia Brose, Mohammad Razaq, Elisabeth Pérez-Ruiz, Ezra E W Cohen, Rahul Aggarwal, Catherine Scholz, Antonio Gualberto, and Alan L Ho (Article)

Link

Utilization of Emicizumab in Acquired Factor VIII Deficiency., Kevin J. Hess DO, Preysi Patel DO, Amogh M. Joshi DO, and Adam J. Kotkiewicz DO (Article)

Link

PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer., Robert A Huddart, Arlene O Siefker-Radtke, Arjun V Balar, Mehmet A Bilen, Thomas Powles, Aristotelis Bamias, Daniel Castellano, Maged Khalil MD, Michiel S Van Der Heijden, Vadim S Koshkin, David W Pook, Mustafa Özgüroğlu, Linda Santiago, Bob Zhong, David Chien, Wei Lin, Mary A Tagliaferri, and Yohann Loriot (Article)

Link

Chemotherapy use and survival in older adults with metastatic pancreatic cancer in the combination therapy era., Rishi Jain, Namrata Vijayvergia, Karthik Devarajan, Bianca Lewis, Crystal S Denlinger, Steven J Cohen, and Efrat Dotan (Article)

PDF

Bad Blood: A Case of Warm Autoimmune Hemolytic Anemia, Amogh M. Joshi DO, Kevin J. Hess DO, Zeeshan Ali MD, and Nicholas Lamparella DO (Poster)

Link

Integrating touchscreen-based geriatric assessment and frailty screening for adults with acute myelogenous leukemia to drive personalized treatment decisions, M Kasner (Article)

Link

Outpatient Vyxeos Induction without Planned Admission for Select Patients with Secondary Acute Myeloid Leukemia (sAML) Is Safe and Yields Healthcare Resource Savings, M Kasner (Article)

Link

Results of the Phase 1b Dose Escalation Study of OPB-111077, Decitabine, and Venetoclax for the Treatment of Newly Diagnosed or Relapsed/Refractory AML, M Kasner (Article)

Link

Socioeconomic Influences on the Treatment and Outcomes of Patients with Acute Myeloid Leukemia: Experience from an Urban Academic Center, M Kasner (Article)

Link

Targeted Oncogene Therapy Before Surgery in Pediatric Patients With Advanced Invasive Thyroid Cancer at Initial Presentation: Is It Time for a Paradigm Shift?, Ken Kazahaya, Kara K Prickett, Vera A Paulson, John P Dahl, Scott C Manning, Erin R Rudzinski, Jeffrey C Rastatter, Sanjay R Parikh, Douglas S Hawkins, Marcia S Brose, and Andrew J Bauer (Article)

Link

PIVOT-10: A phase II study of bempegaldesleukin (NKTR-214) in combination with nivolumab (NIVO) in cisplatin (cis) ineligible patients with previously untreated locally advanced or metastatic urothelial cancer (mUC), Maged Khalil MD (Article)

Link

Case Report: Neuroendocrine Tumor With Cardiac Metastasis., Rachel Kinney DO; Robert V. Decker MD; Deborah W Sundlof DO; Muhammad A. Rizvi MD; and Kelly C. Schadler MSN, CRNP (Article)

PDF

Identifying Baseline Characteristics for Consideration of Prophylactic Feeding Tube Placement in Persons Undergoing Chemoradiotherapy for Head and Neck Cancer: A Retrospective Chart Review, Kenna Kita; Janine Gilboy RD, CSO, LDN; Erin Levine RD, CSO, LDN; Brian J. Patson MD; and Jennifer Brennan MS, RD, CSO (Poster)

Link

Digital Polymerase Chain Reaction Paired with High-Speed Atomic Force Microscopy for Quantitation and Length Analysis of DNA Length Polymorphisms., Sean R Koebley, Andrey Mikheikin, Kevin Leslie, Daniel Guest, Wendy McConnell-Wells, Joshua H Lehman, Taha Al Juhaishi, Xiaojie Zhang, Catherine H Roberts, Loren Picco, Amir Toor MD, Alden Chesney, and Jason Reed (Article)

Link

Inhibitory KIR-Ligand Interactions and Relapse Protection Following HLA Matched Allogeneic HCT for AML, Elizabeth Krieger, Rehan Qayyum, and Amir Toor MD (Article)

Link

Killer Immunoglobulin-Like Receptor-Ligand Interactions Predict Clinical Outcomes following Unrelated Donor Transplantations., Elizabeth Krieger, Roy Sabo, Sanauz Moezzi, Caitlin Cain, Catherine Roberts, Pamela Kimball, Alden Chesney, John McCarty, Armand Keating, Rizwan Romee, Christina Wiedl, Rehan Qayyum, and Amir Toor MD (Article)

Link

Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions., Elizabeth Krieger and Amir Toor MD (Article)

Link

Immunological determinants of clinical outcomes in COVID-19, Elizabeth Krieger, Nicole Vissichelli, Stefan Leichtle, Markos Kashioris, Roy Sabo, Donald Brophy, Xiang-Yang Wang, Pamela Kimbal, Michael Neale, Myrna G. Serrano, Gregory A. Buck, Catherine Roberts, Rehan Qayyum, Daniel Nixon, Steven Grossman, and Amir Toor MD (Article)

Nivolumab (NIVO) + low-dose ipilimumab (IPI) as first-line (1L) therapy in microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Two-year clinical update., Heinz-Josef Lenz, Sara Lonardi, Vittorina Zagonel, Eric Van Cutsem, M Luisa Limon, Ka Yeung Mark Wong, Alain Hendlisz, Massimo Aglietta, Pilar Garcia-Alfonso, Bart Neyns, Fabio Gelsomino, Dana Backlund Cardin, Tomislav Dragovitch, Usman Shah MD, Jing Yang, Jean-Marie Ledeine, and Michael J. Overman (Presentation)

Nivolumab plus low-dose ipilimumab as first-line therapy in microsatellite instability-high/DNA mismatch repair deficient metastatic colorectal cancer: Clinical update., Heinz-Josef Lenz, Sara Lonardi, Vittorina Zagonel, Eric Van Cutsem, M Luisa Limon, Ka Yeung Mark Wong, Alain Hendlisz, Massimo Aglietta, Pilar Garcia-Alfonso, Bart Neyns, Andrea Spallanzani, Dana Backlund Cardin, Tomislav Dragovitch, Usman Shah MD, Ajlan Atasoy, Jean-Marie Ledeine, and Michael J. Overman (Presentation)

Link

Pacemaking Activity in the Peripheral Nervous System: Physiology and Roles of Hyperpolarization Activated and Cyclic Nucleotide-Gated Channels in Neuropathic Pain., Fan Liu, George Y Wuni, Ronak Bahuva, Muhammad Ahsan Shafiq, Boula S Gattas, Crystal N Ibetoh, Eugeniu Stratulat, and Domonick K Gordon (Article)

Link

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA., M C Liu, G R Oxnard, E A Klein, C Swanton, M V Seiden, and Maged Khalil MD (Article)

Link

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer., Vicky Makker, Matthew H Taylor, Carol Aghajanian, Ana Oaknin, James Mier, Allen L Cohn, Margarita Romeo, Raquel Bratos, Marcia S Brose, Christopher DiSimone, Mark Messing, Daniel E Stepan, Corina E Dutcus, Jane Wu, Emmett V Schmidt, Robert Orlowski, Pallavi Sachdev, Robert Shumaker, and Antonio Casado Herraez (Article)

Link

A Novel Technique to Minimize Contamination for Cervical Cancer Surgery Patients., Martin A. Martino MD, Kristin Bixel, Andrea M Johnson, Taylor Wejkszner, Aaron Jacobs, Jose Lazaro MD, Elizaveta Makarova, M Bijoy Thomas MD, and Jeffrey Fowler (Article)

Link

M.D. Anderson experience of immune checkpoint inhibitor therapy in classical Hodgkin lymphoma, Ranjit R. Nair MD (Article)